The development of novel antiepileptic drugs is transforming the epilepsy therapeutics market. Pharmaceutical companies are focusing on targeted therapies. These treatments aim to reduce side effects and improve efficacy. The epilepsy market is expanding steadily as the prevalence of neurological disorders continues to rise worldwide. The market is projected to grow from US$ 7.7 billion in...

Neurometabolic Disorders are inherited metabolic conditions that lead to neurological complications. These disorders disrupt the body’s ability to break down or utilize certain nutrients. Early screening and treatment are essential. Neurometabolic Disorders Market Overview The Neurometabolic Disorders Market is gaining increasing attention within the global healthcare industry...